Novel Targeting of Apoptosis Pathways for Prostate Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
85-95
Author(s):
Jason B. Garrison and Natasha Kyprianou
Death Receptors as Targets of Cancer Therapeutics
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
97-104
Author(s):
M. Saeed Sheikh and Ying Huang
Intravenous and Regional Paclitaxel Formulations
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
397-402
Author(s):
Rajendra Pawar, Ariella Shikanov, Boris Vaisman and Abraham J. Domb
Antibodies in Diagnostic Applications
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
9-16
Author(s):
Sergey Y. Tetin and Stephen D. Stroupe
Detection of Tumor Markers with ProteinChip® Technology
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
45-67
Author(s):
Andreas Wiesner
Subject Index to Volume 4
Journal:
Current Drug Targets
Volume:
5
Page:
111-117
Author(s):
Bentham Science Publishers
Erythropoietin Withdrawal Leads to the Destruction of Young Red Cells at the Endothelial-Macrophage Interface
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
183-190
Author(s):
J. Trial and L. Rice
Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello
Antiangiogenic Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
27-37
Author(s):
Daniel Albo, Thomas N. Wang and George P. Tuszynski
The Urokinase Plasminogen Activator System: Role in Malignancy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
39-49
Author(s):
Michael J. Duffy